Government ContextGovernment Context
TopicsAgenciesDocumentsPricingLog inCreate account
TopicsAgenciesDocumentsPricing
LoginCreate account
DetailsRelated

Reference 2. Fox et al 2011 Anticholinergic_medication_use_and_cogni

Supporting & Related MaterialFDA-2026-P-7541-0005
Document

Details

The document's own metadata, straight from the source system.

Title
Reference 2. Fox et al 2011 Anticholinergic_medication_use_and_cogni
Posted
Jul 8, 2026
Agency
Food and Drug Administration (FDA)
View on regulations.gov ↗
Related

Related documents

Other documents filed with this rulemaking.

View related documents
Supporting & Related Material
Reference 1. Gray et al. 2015
No comment periodJul 8, 2026
Supporting & Related Material
Reference 4. Iyen et al. 2024
No comment periodJul 8, 2026
Supporting & Related Material
Reference 6. Pieper et al. 2020
No comment periodJul 8, 2026
Supporting & Related Material
Reference 11. Gray et al. 2018 autopsy study
No comment periodJul 8, 2026
Supporting & Related Material
Reference 10. Risacher et al. 2016
No comment periodJul 8, 2026
Supporting & Related Material
Reference 16. Hampel et al. 2018
No comment periodJul 8, 2026
Supporting & Related Material
Reference 17. Baek et al. 2020
No comment periodJul 8, 2026
Other
Acknowledgment Letter from FDA DMB to Andrew D. Mosholder
No comment periodJul 8, 2026

On this page

DetailsRelated
Government ContextGovernment Context

Track federal rulemaking documents, topics, and agencies — built on primary sources across the federal government.

ExploreDocumentsTopicsAgencies
CompanyAboutData sourcesPricing
LegalPrivacyTerms
© 2026 Government Context. Built on primary government sources.Not affiliated with any U.S. government agency.